查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1360320

經皮皮膚貼片市場（產品類型：儲存庫、藥物黏合劑、基質、微針等；銷售類型：處方藥和非處方藥 [OTC]）－全球產業分析、規模、佔有率、成長、趨勢，以及預測，2023-2031

Transdermal Skin Patches Market (Product Type: Reservoir, Drug-in-Adhesive, Matrix, Microneedle, and Others; and Sales Type: Prescription and Over-the-Counter [OTC]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 186 Pages | 商品交期: 2-10個工作天內

價格

經皮皮膚貼片市場 - 報告範圍

TMR 關於全球經皮皮膚貼片市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球經皮皮膚貼片的收入2017-2031年期間的市場，考慮2023年為基準年，2031年為預測年。該報告也提供了2023年至2031年全球經皮皮膚貼片市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解經皮皮膚貼片市場。

市場概況
2023年市場價值 77 億美元
2031 年市場價值 115 億美元
複合年成長率 4.6%

該報告深入研究了全球經皮皮膚貼片市場的競爭格局。已經確定了全球經皮皮膚貼片市場的主要參與者，並對其中每位參與者的各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球經皮皮膚貼片市場參與者的屬性。

目錄

第 1 章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2017 - 2031 年全球市場分析與預測

第 5 章：關鍵見解

  • 按地區/全球分類的監管情景
  • 全球主要國家的疾病盛行率和發生率
  • 管道分析
  • 主要產品/品牌分析
  • COVID-19 對產業的影響

第 6 章：全球市場分析與預測：依產品類型

  • 簡介與定義
  • 主要發現/進展
  • 2017 - 2031 年按產品類型分類的市場價值預測
    • 水庫
    • 黏合劑中的藥物
      • 單層
      • 多層
    • 微型針
    • 矩陣
    • 其他（蒸氣等）
  • 按產品類型分類的市場吸引力

第 7 章：全球市場分析與預測：按應用分類

  • 簡介與定義
  • 主要發現/進展
  • 2017 - 2031 年按應用的市場價值預測
    • 疼痛管理
    • 荷爾蒙失調
    • 減少吸菸和戒菸援助
    • 神經系統疾病
    • 心血管疾病
    • 其他（暈車、膀胱過動症等）
  • 按應用的市場吸引力

第 8 章：全球市場分析與預測：依銷售類型

  • 簡介與定義
  • 主要發現/進展
  • 2017 - 2031 年按銷售類型分類的市場價值預測
    • 處方
    • 場外交易 (OTC)
  • 按銷售類型分類的市場吸引力

第 9 章：全球市場分析與預測：按配銷通路

  • 簡介與定義
  • 主要發現/進展
  • 2017 - 2031 年按配銷通路分類的市場價值預測
    • 醫院藥房
    • 零售藥局
    • 網路藥局
  • 按配銷通路分類的市場吸引力

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按國家/地區分類的市場吸引力

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 公司市佔率分析 (2022)
  • 公司簡介
    • Hisamitsu Pharmaceutical Co., Inc.
    • Viatris Inc.
    • Nitto Denko Corporation
    • Novartis AG
    • Luye Pharma Group
    • Teikoku Pharma
    • Samyang Holdings Corporation
    • Gedeon Richter PLC
    • AdhexPharma
    • Sparsha Pharma International Pvt. Ltd.
Product Code: TMRGL2245

Transdermal Skin Patches Market - Scope of Report

TMR's report on the global transdermal skin patches market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global transdermal skin patches market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transdermal skin patches market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the transdermal skin patches market.

Market Snapshot
Market Value in 2023US$ 7.7 Bn
Market Value in 2031US$ 11.5 Bn
CAGR4.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transdermal skin patches market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transdermal skin patches market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transdermal skin patches market.

The report delves into the competitive landscape of the global transdermal skin patches market. Key players operating in the global transdermal skin patches market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transdermal skin patches market profiled in this report.

Key Questions Answered in Global Transdermal Skin Patches Market Report:

  • What is the sales/revenue generated by transdermal skin patches across all regions during the forecast period?
  • What are the opportunities in the global transdermal skin patches market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Transdermal Skin Patches Market - Research Objectives and Research Approach

The comprehensive report on the global transdermal skin patches market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global transdermal skin patches market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transdermal skin patches market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transdermal Skin Patches Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Transdermal Skin Patches Market Analysis and Forecast, 2017 - 2031
    • 4.4.1. Market Revenue Projection (US$ Bn)

5. Key Insights

  • 5.1. Regulatory Scenario by Region/Globally
  • 5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
  • 5.3. Pipeline Analysis
  • 5.4. Key Product/brand Analysis
  • 5.5. COVID-19 Impact on the Industry

6. Global Transdermal Skin Patches Market Analysis and Forecast, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2017 - 2031
    • 6.3.1. Reservoir
    • 6.3.2. Drug-in-Adhesive
      • 6.3.2.1. Single Layer
      • 6.3.2.2. Multilayer
    • 6.3.3. Microneedle
    • 6.3.4. Matrix
    • 6.3.5. Others (Vapor, etc.)
  • 6.4. Market Attractiveness By Product Type

7. Global Transdermal Skin Patches Market Analysis and Forecast, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2017 - 2031
    • 7.3.1. Pain Management
    • 7.3.2. Hormonal Disorders
    • 7.3.3. Smoking Reduction and Cessation Aid
    • 7.3.4. Neurological Disorders
    • 7.3.5. Cardiovascular Disorders
    • 7.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 7.4. Market Attractiveness By Application

8. Global Transdermal Skin Patches Market Analysis and Forecast, By Sales Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Sales Type, 2017 - 2031
    • 8.3.1. Prescription
    • 8.3.2. Over-the-Counter (OTC)
  • 8.4. Market Attractiveness By Sales Type

9. Global Transdermal Skin Patches Market Analysis and Forecast, By Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness By Distribution Channel

10. Global Transdermal Skin Patches Market Analysis and Forecast, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Transdermal Skin Patches Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2017 - 2031
    • 11.2.1. Reservoir
    • 11.2.2. Drug-in-Adhesive
      • 11.2.2.1. Single Layer
      • 11.2.2.2. Multilayer
    • 11.2.3. Microneedle
    • 11.2.4. Matrix
    • 11.2.5. Others (Vapor, etc.)
  • 11.3. Market Value Forecast By Application, 2017 - 2031
    • 11.3.1. Pain Management
    • 11.3.2. Hormonal Disorders
    • 11.3.3. Smoking Reduction and Cessation Aid
    • 11.3.4. Neurological Disorders
    • 11.3.5. Cardiovascular Disorders
    • 11.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 11.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 11.4.1. Prescription
    • 11.4.2. Over-the-Counter (OTC)
  • 11.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast By Country, 2017 - 2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Application
    • 11.7.3. By Sales Type
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Transdermal Skin Patches Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2017 - 2031
    • 12.2.1. Reservoir
    • 12.2.2. Drug-in-Adhesive
      • 12.2.2.1. Single Layer
      • 12.2.2.2. Multilayer
    • 12.2.3. Microneedle
    • 12.2.4. Matrix
    • 12.2.5. Others (Vapor, etc.)
  • 12.3. Market Value Forecast By Application, 2017 - 2031
    • 12.3.1. Pain Management
    • 12.3.2. Hormonal Disorders
    • 12.3.3. Smoking Reduction and Cessation Aid
    • 12.3.4. Neurological Disorders
    • 12.3.5. Cardiovascular Disorders
    • 12.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 12.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 12.4.1. Prescription
    • 12.4.2. Over-the-Counter (OTC)
  • 12.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast By Country, 2017 - 2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Application
    • 12.7.3. By Sales Type
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country

13. Asia Pacific Transdermal Skin Patches Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2017 - 2031
    • 13.2.1. Reservoir
    • 13.2.2. Drug-in-Adhesive
      • 13.2.2.1. Single Layer
      • 13.2.2.2. Multilayer
    • 13.2.3. Microneedle
    • 13.2.4. Matrix
    • 13.2.5. Others (Vapor, etc.)
  • 13.3. Market Value Forecast By Application, 2017 - 2031
    • 13.3.1. Pain Management
    • 13.3.2. Hormonal Disorders
    • 13.3.3. Smoking Reduction and Cessation Aid
    • 13.3.4. Neurological Disorders
    • 13.3.5. Cardiovascular Disorders
    • 13.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 13.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 13.4.1. Prescription
    • 13.4.2. Over-the-Counter (OTC)
  • 13.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast By Country, 2017 - 2031
    • 13.6.1. Japan
    • 13.6.2. China
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Application
    • 13.7.3. By Sales Type
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country

14. Latin America Transdermal Skin Patches Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2017 - 2031
    • 14.2.1. Reservoir
    • 14.2.2. Drug-in-Adhesive
      • 14.2.2.1. Single Layer
      • 14.2.2.2. Multilayer
    • 14.2.3. Microneedle
    • 14.2.4. Matrix
    • 14.2.5. Others (Vapor, etc.)
  • 14.3. Market Value Forecast By Application, 2017 - 2031
    • 14.3.1. Pain Management
    • 14.3.2. Hormonal Disorders
    • 14.3.3. Smoking Reduction and Cessation Aid
    • 14.3.4. Neurological Disorders
    • 14.3.5. Cardiovascular Disorders
    • 14.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 14.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 14.4.1. Prescription
    • 14.4.2. Over-the-Counter (OTC)
  • 14.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast By Country, 2017 - 2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Application
    • 14.7.3. By Sales Type
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country

15. Middle East & Africa Transdermal Skin Patches Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product Type, 2017 - 2031
    • 15.2.1. Reservoir
    • 15.2.2. Drug-in-Adhesive
      • 15.2.2.1. Single Layer
      • 15.2.2.2. Multilayer
    • 15.2.3. Microneedle
    • 15.2.4. Matrix
    • 15.2.5. Others (Vapor, etc.)
  • 15.3. Market Value Forecast By Application, 2017 - 2031
    • 15.3.1. Pain Management
    • 15.3.2. Hormonal Disorders
    • 15.3.3. Smoking Reduction and Cessation Aid
    • 15.3.4. Neurological Disorders
    • 15.3.5. Cardiovascular Disorders
    • 15.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 15.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 15.4.1. Prescription
    • 15.4.2. Over-the-Counter (OTC)
  • 15.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies
  • 15.6. Market Value Forecast By Country, 2017 - 2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of the Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Application
    • 15.7.3. By Sales Type
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Hisamitsu Pharmaceutical Co., Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Viatris Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Nitto Denko Corporation
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Novartis AG
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Luye Pharma Group
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Teikoku Pharma
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Samyang Holdings Corporation
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Gedeon Richter PLC
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. AdhexPharma
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Sparsha Pharma International Pvt. Ltd.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 1. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 2. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 3. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 4. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 5. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 6. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 7. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 8. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 9. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 10. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 11. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 12. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 13. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 14. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 15. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 16. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 17. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 18. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 19. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 20. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 21. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 22. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 23. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 24. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 25. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 26. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 27. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 28. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 29. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 30. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031

List of Figures

  • Figure 1. Global Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 2. Global Transdermal Skin Patches Market Value Share by Product Type, 2017-2031
  • Figure 3. Global Transdermal Skin Patches Market Value Share by Application, 2017-2031
  • Figure 4. Global Transdermal Skin Patches Market Value Share by Sales Type, 2017-2031
  • Figure 5. Global Transdermal Skin Patches Market Value Share by Distribution Channel, 2017-2031
  • Figure 6. Global Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 7. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Reservoir, 2017-2031
  • Figure 8. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Drug-in-Adhesive, 2017-2031
  • Figure 9. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Microneedle, 2017-2031
  • Figure 10. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Matrix, 2017-2031
  • Figure 11. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Others, 2017-2031
  • Figure 12. Global Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 13. Global Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 14. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Pain Management, 2017-2031
  • Figure 15. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Hormonal Disorders, 2017-2031
  • Figure 16. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Smoking Reduction and Cessation Aid, 2017-2031
  • Figure 17. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Neurological Disorders, 2017-2031
  • Figure 18. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Cardiovascular Disorders, 2017-2031
  • Figure 19. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Others, 2017-2031
  • Figure 20. Global Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 21. Global Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 22. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Prescription, 2017-2031
  • Figure 23. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Over-the-Counter (OTC), 2017-2031
  • Figure 24. Global Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
  • Figure 25. Global Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022 and 2031
  • Figure 26. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Hospital Pharmacies, 2017-2031
  • Figure 27. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Retail Pharmacies, 2017-2031
  • Figure 28. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Online Pharmacies, 2017-2031
  • Figure 29. Global Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 30. Global Transdermal Skin Patches Market Value Share Analysis by Region, 2022 and 2031
  • Figure 31. Global Transdermal Skin Patches Market Attractiveness Analysis by Region, 2023-2031
  • Figure 32. North America Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 33. North America Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 34. North America Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
  • Figure 35. North America Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 36. North America Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 37. North America Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 38. North America Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 39. North America Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 40. North America Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
  • Figure 41. North America Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022 and 2031
  • Figure 42. North America Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 43. Europe Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 44. Europe Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 45. Europe Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
  • Figure 46. Europe Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 47. Europe Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 48. Europe Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 49. Europe Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 50. Europe Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 51. Europe Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
  • Figure 52. Europe Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022 and 2031
  • Figure 53. Europe Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 54. Asia Pacific Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 55. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 56. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
  • Figure 57. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 58. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 59. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 60. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 61. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 62. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
  • Figure 63. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022-2031
  • Figure 64. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 65. Latin America Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 66. Latin America Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 67. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
  • Figure 68. Latin America Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 69. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 70. Latin America Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 71. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 72. Latin America Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 73. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2022-2031
  • Figure 74. Latin America Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022-2031
  • Figure 75. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 76. Middle East & Africa Transdermal Skin Patches Market Value (US$ Bn), 2017-2031
  • Figure 77. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 78. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Country, 2023-2031
  • Figure 79. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 80. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Product Type, 2023-2031
  • Figure 81. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 82. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Application, 2023-2031
  • Figure 83. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 84. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Sales Type, 2023-2031
  • Figure 85. Middle East & Africa Transdermal Skin Patches Market Value Share by Distribution Channel, 2022 and 2031
  • Figure 86. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Distribution Channel, 2023-2031
  • Figure 87. Company Share Analysis Transdermal Skin Patches, 2022